Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Neumeister, P; Prochazka, KT.
Antibody-drug conjugates in the treatment of lymphoid neoplasms
MEMO-MAG EUR MED ONC. 2024;
Doi: 10.1007/s12254-024-00965-x
Web of Science
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Neumeister Peter
- Co-authors Med Uni Graz
- Prochazka Katharina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Antibody-drug conjugates (ADCs) are a new class of monoclonal antibodies with the characteritic to specifically target tumor cells and to deliver a cytotoxic drug directly to the target cell thereby minimising side effects and improving the therapeutic index. In recent years, many new ADCs have been approved and are established therapeutic tools in lymphoma treatment.
- Find related publications in this database (Keywords)
- Brentuximab vedotin
- Polatuzumab vedotin
- Loncastuximab tesirine
- Inotuzumab ozogamicin
- Diffuse large B-cell lymphoma
- Hodgkin's lymphoma